Johnson & Johnson Rallybio Corp Transaction History
Johnson & Johnson
- $427 Million
- Q3 2025
A detailed history of Johnson & Johnson transactions in Rallybio Corp stock. As of the latest transaction made, Johnson & Johnson holds 3,636,363 shares of RLYB stock, worth $2.33 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
3,636,363
Previous 3,636,363
-0.0%
Holding current value
$2.33 Million
Previous $1.24 Million
61.73%
% of portfolio
0.47%
Previous 0.42%
Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
46Shares Held
28.9MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$2.68 Million0.01% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$2.32 Million1.34% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$2.11 Million4.2% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$1.94 Million0.11% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA2.4MShares$1.54 Million1.19% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $20.6M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...